Intravascular lithotripsy for coral reef aortic stenosis: a case series assessing feasibility, hemodynamic effects,
Marios Platon Dimopoulos1,2, Maria Papageorgiou3, Georgios Nistikoulis4,3
1Department of Interventional Radiology, University Hospital of Patras, Patras, 26504, Greece. dimopoylos.platonas@gmail.com.
Insights
Intravascular lithotripsy (IVL) combined with fractional flow reserve (FFR) offers a safe and effective minimally invasive treatment for severe calcified aortic stenosis. This approach improves blood flow and may reduce the need for stenting in high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Surgery
Background:
- Coral reef aorta (CRA) involves calcified plaques obstructing the aorta, with open surgery posing high risks.
- Endovascular techniques, like intravascular lithotripsy (IVL), present less invasive options for treating aortic stenosis.
- High-risk patients often face significant morbidity with traditional surgical interventions.
Purpose of the Study:
- To assess the feasibility, safety, and hemodynamic effects of IVL guided by FFR in treating calcified aortic stenosis.
- To evaluate the efficacy of IVL in modifying calcified aortic plaques and restoring hemodynamic flow.
- To determine if IVL combined with FFR can reduce the need for stent implantation.
Main Methods:
- A case series of three patients with severe calcified abdominal aortic stenosis was conducted.
- Intravascular lithotripsy (IVL) was employed under fractional flow reserve (FFR) guidance.
- Pre- and post-procedural FFR measurements were utilized to assess hemodynamic significance and treatment outcomes.
Main Results:
- All IVL procedures were technically successful, with significant FFR improvements post-treatment.
- IVL effectively modified calcified plaques, achieving adequate luminal gain in most cases without stenting.
- One patient experienced an aortic dissection, managed successfully with stent placement.
- Follow-up showed sustained clinical improvement and vessel patency up to 12 months.
Conclusions:
- IVL combined with FFR is a feasible and effective minimally invasive strategy for managing heavily calcified aortic lesions.
- This combined approach allows for both plaque modification and objective physiological assessment.
- The IVL-FFR strategy shows potential for reducing stent implantation in treating calcified aortic stenosis.
Abstract:
Coral reef aorta (CRA) is defined by the presence of heavily calcified exophytic plaques that protrude into the aortic lumen. Open surgery remains the standard treatment but is associated with substantial morbidity, particularly in high-risk patients. Endovascular approaches, including intravascular lithotripsy (IVL), have emerged as less invasive alternatives. This case series aimed to evaluate the feasibility, safety, and hemodynamic impact of IVL combined with fractional flow reserve (FFR) in the treatment of calcified aortic stenoses. We present a case series of three patients with severe calcified abdominal aortic stenosis treated with IVL under FFR guidance. Pre- and post-procedural FFR measurements were used to assess lesion hemodynamic significance and treatment efficacy. All procedures were technically successful, with significant improvement in FFR values following IVL, indicating restoration of hemodynamic flow. One case was complicated by an aortic dissection, successfully managed with stent placement. In the remaining cases, IVL achieved adequate luminal gain without the need for stenting. At follow-up (up to 12 months), all patients demonstrated sustained clinical improvement and maintained vessel patency. IVL combined with FFR appears to be a feasible and effective minimally invasive approach for the management of heavily calcified aortic lesions. This strategy allows both morphological plaque modification and objective physiological assessment, potentially reducing the need for stent implantation. Larger studies are required to validate these findings.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
